Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.41 |
| ▸ | MGLL | Q99685 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | PARL | Q9H300 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13455758 | 0.94 | SMN1; SMN2 (0.44) | CA12CA1CA9ALDH1A1HPGD | |
| SCHEMBL5648489 | 0.92 | CA12 (0.47) | CA12CA1CA9ALDH1A1HPGD | |
| SCHEMBL27717830 | 0.92 | CA1 (0.55) | CA12CA1CA9ALDH1A1HPGD | |
| SCHEMBL159204 | 0.91 | KDM4E (0.42) | CA1ALDH1A1HPGDKMT2AMGLL | |
| SCHEMBL16005095 | 0.91 | ALDH1A1 (0.37) | CA12CA1CA9ALDH1A1HPGD | |
| SCHEMBL1696262 | 0.91 | KDM4E (0.42) | CA1ALDH1A1HPGDKMT2AMGLL | |
| SCHEMBL3565689 | 0.91 | MAPT (0.42) | CA12CA1CA9ALDH1A1HPGD | |
| SCHEMBL12216547 | 0.91 | LMNA (0.44) | CA12CA1CA9ALDH1A1HPGD | |
| SCHEMBL1800956 | 0.91 | PTPRF (0.44) | CA1ALDH1A1HPGDLMNASMN1; SMN2 | |
| SCHEMBL317627 | 0.91 | PTPN2 (0.44) | CA12CA1CA9ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4536653-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | Eisai R&D Management Co., Ltd. (JP) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023239906-A2 | SIALIC ACID DERIVATIVES AND METHODS OF USING SAME | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2023-12-14 | — | — | WO | disclosed |
| US-20230357767-A1 | NOVEL NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF TARGET GENE | BONAC CORPORATION (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230357767-A1 | NOVEL NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF TARGET GENE | BONAC CORPORATION (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230310551-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | MERCK SHARP & DOHME LLC (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230310551-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | MERCK SHARP & DOHME LLC (US) | 2023-10-05 | — | — | US | disclosed |
| EP-4204441-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | Merck Sharp & Dohme LLC (US) | 2023-07-05 | — | — | EP | disclosed |
| WO-2022046739-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | MERCK SHARP & DOHME CORP. (US) | 2022-03-03 | — | — | WO | disclosed |
| US-20210340276-A1 | COMPLEX HAVING ANTI-HUMAN MUC1 ANTIBODY FAB FRAGMENT, PEPTIDE LINKER AND/OR LIGAND | ASTELLAS PHARMA INC. (JP) | 2021-11-04 | — | — | US | disclosed |
| US-10913743-B2 | Use of organic oxyimides as flame retardant for plastic materials and also flame-retardant plastic material composition and moulded parts produced therefrom | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2021-02-09 | — | — | US | disclosed |
| EP-0803377-A1 | Recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1997-10-29 | — | — | EP | disclosed |
| US-5047308-A | Microencapsulationof diazo compound or coupler | FUJI PHOTO FILM CO., LTD. (JP) | 1991-09-10 | — | — | US | disclosed |
| US-5028580-A | Heat sensitive recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1991-07-02 | — | — | US | disclosed |
| US-4999333-A | For facsimile and thermal printing | FUJI PHOTO FILM CO., LTD. (JP) | 1991-03-12 | — | — | US | disclosed |
| US-4990482-A | Transparent | FUJI PHOTO FILM CO., LTD. (JP) | 1991-02-05 | — | — | US | disclosed |
| US-4956251-A | Multilayer, multicolor recording media, radiation transparent protective coatings | FUJI PHOTO FILM CO., LTD. (JP) | 1990-09-11 | — | — | US | disclosed |
| US-4929411-A | Heat-sensitive recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1990-05-29 | — | — | US | disclosed |
| US-4857941-A | Multicolor thermal recording device | FUJI PHOTO FILM CO., LTD. (JP) | 1989-08-15 | — | — | US | disclosed |
| US-4547445-A | WATERPROOF SUPPORT OF POLYOLEFIN COATED PAPER; ONE SIDE CONTAINS PHOTOGRAPHIC EMULSION; OTHER A HARDENED, PIGMENTED | FUJI PHOTO FILM CO., LTD. (JP) | 1985-10-15 | — | — | US | disclosed |
| US-4232117-A | HYDROPHILIC COLLOID LAYERS CONTAINING GELATIN, MATTING AGENT, COLLOIDAL SILICA AND POLYMER LATEX | FUJI PHOTO FILM CO., LTD. (JP) | 1980-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357767-A1 | NOVEL NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF TARGET GENE | SNRPE, DDX21, DCLRE1B | CA12 4333/4885CA1 4028/4885CA9 4178/4885 |
| US-20210340276-A1 | COMPLEX HAVING ANTI-HUMAN MUC1 ANTIBODY FAB FRAGMENT, PEPTIDE LINKER AND/OR LIGAND | MUC1, SIGLEC7, CA14 | CA12 6/4885CA1 165/4885CA9 223/4885 |
| US-10913743-B2 | Use of organic oxyimides as flame retardant for plastic materials and also flame-retardant plastic material composition and moulded parts produced therefrom | ORMDL3, OGDH, FTO | CA12 2921/4885CA1 2945/4885CA9 3099/4885 |
| US-20230310551-A1 | INSULIN RECEPTOR PARTIAL AGONISTS | INSR, GPR119, IRS1 | CA12 4655/4885CA1 4717/4885CA9 4721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.